Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Dr. Eric Winer
Based on 213 articles published since 2007
||||
Expertise Level
The expertise of Dr. Eric Winer ranks in the
  • Top 0.0051%
  • ... of 254,621 published authors worldwide on Breast Neoplasms
  • ... from 2007 through 2018
  • ... based on contributions to 213 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Winer, E   ·   Winer, E P   ·   Winer, Eric P   ·   Winer, Eric
Work Locations
Details
Most likely:    Harvard University   Contact    
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore, USA. · Indiana University Medical CTR, Indianapolis, USA. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Pubmed 27927580
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts3Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts. · Department of Medicine, University of North Carolina, Chapel Hill. · Department of Medical Oncology, City of Hope, Duarte, California. · Pubmed 27892991
  • Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. · Division of Public Health Science, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri. · Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Stanford University School of Medicine, Stanford, California. · Department of Medicine, Duke Cancer Institute, Durham, North Carolina. · Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri. · Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Medical Oncology, University of Southern California, Los Angeles, California. · Medical Oncology, Rush University Medical Center, Chicago, Illinois. · Department of Medicine, University of Alabama Birmingham, Birmingham, Alabama. · Department of Oncology-Hematology, St. Luke's Cancer Institute, Kansas City, Missouri. · Department of Medicine, University of North Carolina, Chapel Hill, North Carolina. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Guardant Health Inc., Redwood City, California. · Puma Biotechnology, Los Angeles, California. · Genomic and Pathology Service, Washington University School of Medicine, St. Louis, Missouri. · Department of Hematology and Oncology, University of Michigan, Ann Arbor, Michigan. · Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California. · Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas. · Pubmed 28679771
  • Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · University of Chicago, Chicago, Illinois, USA. · NorthShore University Health System, Evanston, Illinois, USA. · State Key Laboratory of Natural and Biomimetic Drugs (Peking University), Beijing, China. · Alliance Statistics and Data Center, Duke University, Durham, North Carolina, USA. · Memorial Sloan Kettering Cancer Center, New York, New York, USA. · Dana-Farber/Partners CancerCare/ Harvard Cancer Center, Boston, Massachusetts, USA. · Heartland Cancer Research NCORP, St. Louis, Missouri, USA. · Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. · Mayo Clinic, Rochester, Minnesota, USA. · John H. Stroger Jr Hospital of Cook County, Chicago, Illinois, USA. · Decatur Memorial Hospital/Cancer Care Specialists of Illinois/ Heartland Cancer Research NCORP, Decatur, Illinois, USA. · University of California-San Francisco, San Francisco, California, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, Baltimore, Maryland, USA. · Center for Translational Medicine, School of Pharmacy, University of Maryland, 20 N Pine Street, Room 513, Baltimore, Maryland, 21201, USA. · Pubmed 28620884
  • Department of Radiology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Radiology and Radiological Science, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee. · Department of Medicine, Dana Farber Cancer Institute, Boston, Massachusetts. · Genentech, Inc., South San Francisco, California. · Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York. · Pubmed 28011460
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston,USA. · Division of Hematology and Oncology, Beth Israel Deaconess Medical Center, Boston, USA. · Department of Hematology and Oncology, Massachusetts General Hospital, Boston, USA. · Department of Gynecologic Oncology, MD Anderson Cancer Center, Houston, USA. · Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA. · Memorial Sloan Kettering Cancer Center, New York, USA. · Department of Systems Biology, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center, Houston, USA. · Weill Cornell Medical College, New York, USA. · Pubmed 27993796
  • Dana-Farber Cancer Institute, Boston, Massachusetts, USA · Department of Medicine, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Research Institute, Boston, Massachusetts, USA. · Brigham and Women's Hospital, Boston, Massachusetts, USA. · Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital Research Institute, Boston, Massachusetts, USA · Pubmed 27789775
  • Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Vanderbilt-Ingram Cancer Center (VICC), Vanderbilt University, Nashville, Tennessee. · Massachusetts General Hospital (MGH), Boston, Massachusetts. · Memorial Sloan-Kettering Cancer Center (MSKCC), New York, New York. · The University of Texas MD Anderson Cancer Center, Houston, Texas. · Weill Cornell Medical College, New York, New York. · Dana-Farber Cancer Institute (DFCI), Boston, Massachusetts. · Pubmed 27126994
  • Novant Health Forsyth Medical Center, 3333 Silas Creek Parkway, Winston-Salem, NC, 27103, USA. · Mayo Clinic, Alliance Statistics and Data Center, Rochester, MN, USA. · Mayo Clinic, Rochester, MN, USA. · City of Hope, Duarte, CA, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Dana-Farber/Partners CancerCare, Boston, MA, USA. · MedStar Georgetown University Hospital, Washington, DC, USA. · University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Pubmed 28825227
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Department of Medicine, Harvard Medical School, Boston, Massachusetts 02115, USA. · Hematology Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri 63110, USA. · Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, Texas 77030, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, Massachusetts 02115, USA. · Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston, Massachusetts 02115, USA. · Harvard Stem Cell Institute, Harvard Medical School, Boston, Massachusetts 02115, USA. · Broad Institute of Harvard and MIT, Cambridge, Massachusetts 02142, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 28813415
  • Cancer Prevention and Control Program, Department of Oncology, MedStar Georgetown University School of Medicine, Lombardi Comprehensive Cancer Center, 3300 Whitehaven Street, NW - Suite 4100, Washington, DC, 20007, USA. · Department of Biostatistics, Bioinformatics and Biomathematics, MedStar Georgetown University Medical Center, Georgetown University, Washington, DC, USA. · Division of Oncology, Department of Medicine, Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. · Breast Cancer Program, Departments of Medicine and Oncology, Georgetown University School of Medicine, Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Alliance Statistics and Data Center, Duke University, Durham, NC, USA. · Department of Biostatistics, Dana Farber Cancer Institute, Boston, MA, USA. · Alliance Statistics and Data Center, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Dana-Farber/Partners CancerCare, Boston, MA, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · UNC Lineberger Comprehensive Cancer Center and Department of Medicine, University of North Carolina, Chapel Hill, NC, USA. · Department of Medicine and Center for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA. · Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA. · Pubmed 28364214
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Scottsdale, Arizona. · Pubmed 28323331
  • Duke Cancer Institute, Duke University Medical Center, Box 3204, Durham, NC, 29910, USA. · Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA. · Department of Oncology, MedStar Georgetown University Medical Center, Washington, DC, USA. · Department of Biostatistics, Biomathematics and Bioinformatics, Georgetown University, Washington, DC, USA. · Duke Cancer Institute, Duke University Medical Center, Box 3204, Durham, NC, 29910, USA. · Alliance Statistics and Data Center, Duke University, Durham, NC, USA. · Division of Biostatistics and Epidemiology, Weill Medical College of Cornell University, New York, NY, USA. · Hofstra-North Shore LIJ School of Medicine, Northwell Health Cancer Institute, Lake Success, NY, USA. · Dana-Farber/Partners CancerCare, Boston, MA, USA. · University of Chicago Comprehensive Cancer Center, Chicago, IL, USA. · Wake Forest University School of Medicine, Winston-Salem, NC, USA. · Forsyth Regional Cancer Center, Winston-Salem, NC, USA. · American Society of Clinical Oncology, Alexandria, VA, USA. · UNC Lineberger Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Mayo Clinic, Rochester, MN, USA. · City of Hope, Duarte, CA, USA. · Department of Oncology and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, MedStar Georgetown University Medical Center, Georgetown University, Washington, DC, USA. · Pubmed 28283904
  • Department of Surgery, University of North Carolina, at Chapel Hill, Chapel Hill, NC. Electronic address: · Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC. · Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX. · Department of Medical Oncology, University of North Carolina, at Chapel Hill, Chapel Hill, NC. · Program in Women's Oncology, Women and Infants Hospital of Rhode Island, Providence, RI; Alpert Medical School of Brown University, Providence, RI. · Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA. · Department of Surgery, Brigham and Women's Hospital, Boston, MA. · Pubmed 28089784
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Alliance Statistics and Data Center, Mayo Clinic and Mayo Cancer Center, Rochester, MN, USA. · Mayo Clinic College of Medicine, Rochester, MN, USA. · Duke University School of Medicine, Durham, NC, USA. · Department of Medical Oncology and Therapeutics Research and Department of Population Sciences, City of Hope, Duarte, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Division of Hematology/Oncology, University of North Carolina, Chapel Hill, NC, USA. · Department of Hematology and Oncology, Wake Forest University, Winston-Salem, NC, USA. · ProHEALTH Care Associates, Lake Success, NY, USA. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Division of Hematology and Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA. · Pubmed 27866278
2016
  • From the Division of Hematology-Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill (L.A.C.); and the Breast Oncology Program, Dana-Farber Cancer Institute, Boston (E.P.W.). · Pubmed 27406352
  • Department of Medical Oncology, Breast Oncology Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Oncology Department, Hadassah Hebrew University Medical Center, Jerusalem, Israel. · Department of Oncology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. · Department of General Medical Oncology, Leuven Cancer Institute, KU Leuven, Louvain, Belgium. · Medical Oncology, Institut Jules Bordet, Universite Libre de Bruxelles, Brussels, Belgium. · Willamette Valley Cancer Institute, RiverBend Pavilion, Springfield, OR, USA. · Exelixis, South San Francisco, CA, USA. · Department of Medical Oncology, Breast Oncology Center, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 27714541
  • Susan F. Smith Center for Women's Cancers, Dana Farber Cancer Institute, Boston, Massachusetts. · Center for Functional Caner Epigenetics, Dana Farber Cancer Institute, Boston, Massachusetts. · Susan F. Smith Center for Women's Cancers, Dana Farber Cancer Institute, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana Farber Cancer Institute, Boston, Massachusetts. · Translational Research Unit, Hospital of Prato, Istituto Toscano Tumori, Prato, Italy. · "Sandro Pitigliani" Medica Oncology Unit, Istituto Toscano Tumori, Prato, Italy. · Astra Zeneca Pharmaceuticals, Macclesfield, United Kingdom. · Pubmed 27185372
  • Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. · Peninsula Oncology Centre, Melbourne, VIC, Australia. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · The Royal Marsden Hospital, London, UK. · Hospital Arnau de Vilanova, Lleida, Spain. · Sarah Cannon Research Institute, and Tennessee Oncology, Nashville, TN, USA. · Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic. · University of Alabama, Birmingham, AL, USA. · National University Hospital, Singapore. · Royal Melbourne Hospital, Parkville, VIC, Australia. · Masaryk Memorial Cancer Institute, Brno, Czech Republic. · Herlev University Hospital, Copenhagen, Denmark. · Mayo Clinic, Jacksonville, FL, USA. · Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Washington University School of Medicine, St Louis, MO, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Genentech, South San Francisco, CA, USA. · Barts Cancer Institute, Queen Mary University of London, London, UK. · Pubmed 27155741
  • Stanford University School of Medicine, Stanford, California. · Myriad Genetics Inc., Salt Lake City, Utah. · University of Texas MD Anderson Cancer Center, Houston, Texas. · Denmark Technical University, Lyngby, Denmark. Children's Hospital Boston, Boston, Massachusetts. Harvard Medical School, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. Massachusetts General Hospital, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. Dana-Farber Cancer Institute, Boston, Massachusetts. · Harvard Medical School, Boston, Massachusetts. Dana-Farber Cancer Institute, Boston, Massachusetts. Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 26957554
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. · Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, Ohio. · Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio. · Curis, Inc., Lexington, Massachusetts. · Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, Connecticut. · City of Hope National Medical Center, Duarte, California. · Lifespan Comprehensive Cancer Center, Warren Alpert Medical School of Brown University, Providence, Rhode Island. · Women and Infants Hospital, Warren Alpert Medical School of Brown University, Providence, Rhode Island. · Case Western Reserve University School of Medicine, Cleveland, Ohio. · Pubmed 26842237
  • Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Oncoclinicas do Brasil, Rua Maranhão 569/4, São Paulo 01240-001, Brazil. · Department of Surgery, Dana Farber/Brigham and Women's Cancer Center, 75 Francis Street, Boston, MA 02115, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Pubmed 27721193
  • Department of Surgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA. · Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, USA. · Program in Women's Oncology, Women and Infants Hospital of Rhode Island and Alpert Medical School of Brown University, Providence, RI, USA. · Department of Medical Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Alliance Statistics and Data Center, M D Anderson Cancer Center, Houston, TX, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, University of Michigan, Ann Arbor, MI, USA. · Department of Medical Oncology, City of Hope Medical Center, Los Angeles, CA, USA. · Department of Surgery, Mount Sinai School of Medicine, New York, NY, USA. · Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Pubmed 27704226
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 27484879
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Cell Biology, Harvard Medical School, Boston, Massachusetts. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Cell Biology, Harvard Medical School, Boston, Massachusetts. · Pubmed 27330058
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Academic Unit of Medical Oncology, IRCCS AOU San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Surgical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 27271765
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Lurie Family Imaging Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA. · School of Public Health, Yale University, New Haven, Connecticut, USA. · Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Pubmed 27270588
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Department of Pathology, Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, MA 02215, USA; Center for Functional Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. · Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA; School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, NSW 2052, Australia. · Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA. · Department of Pathology, Yale University, New Haven, CT 06520, USA. · Case Western Reserve School of Medicine, Cleveland, OH 44106, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA; The Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: · Pubmed 26977878
  • Nadine Tung, Beth Israel Deaconess Medical Center; Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Dana-Farber Cancer Institute; Nadine Tung, Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Harvard Medical School, Boston, MA; and John Kidd, Brian A. Allen, Nanda Singh, Richard J. Wenstrup, and Anne-Renee Hartman, Myriad Genetic Laboratories, Inc., Salt Lake City, UT. · Nadine Tung, Beth Israel Deaconess Medical Center; Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Dana-Farber Cancer Institute; Nadine Tung, Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Harvard Medical School, Boston, MA; and John Kidd, Brian A. Allen, Nanda Singh, Richard J. Wenstrup, and Anne-Renee Hartman, Myriad Genetic Laboratories, Inc., Salt Lake City, UT. · Pubmed 26976419
  • Breast Oncology Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Department of Statistics and Computation Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. · Pubmed 26872302
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Massachusetts General Hospital, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26868124
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Department of Medicine, Brigham and Women's Hospital, and Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts USA. · Princess Margaret Cancer Center/University Health Network, Toronto, Ontario, M5G1L7, Canada. · Department of Medical Biophysics, University of Toronto, Toronto, Ontario, M5G2M9, Canada. · Harvard University, Cambridge, Massachusetts, USA. · Cancer Research UK, Cambridge Institute, University of Cambridge, UK, CB2 0RE. · Department of Pathology, Brigham and Women's Hospital, and Department of Pathology, Harvard Medical School, Boston, Massachusetts, USA. · Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Simmons Comprehensive Cancer Center, Departments of Biochemistry and Pharmacology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · Whitehead Institute for Biomedical Research, Cambridge, Massachusetts, USA. · Broad Institute, Cambridge, Massachusetts, USA. · Pubmed 26735014
  • Department of Medical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts. · Department of Surgical Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 26658500
  • Cancer Institute, The Second Hospital of Dalian Medical University, Dalian, China. · Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biochemistry, Goodman Cancer Research Centre, McGill University, Montreal, Quebec, Canada. · Department of Medicine, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN, USA. · Pubmed 26640141
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, New York. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Breast Cancer Research, Sarah Cannon Research Institute, Nashville, Tennessee. · Department of Medicine, Duke University Medical Center, Durham, North Carolina. · Department of Medicine, Cardinal Bernardin Cancer Center, Loyola University Chicago, Chicago, Illinois. · Department of Medicine, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco. · Department of Medicine, Melvin and Bren Simon Cancer Center, Indiana University, Indianapolis. · Department of Medicine, Washington University School of Medicine, St Louis, Missouri. · Department of Hematology Oncology, Hofstra North Shore-Long Island Jewish School of Medicine, Hempstead, New York. · Department of Oncology, The Sydney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland. · Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill. · Department of Medicine, Massachusetts General Hospital, Boston. · Department of Medicine, Cardio-Oncology Program, Vanderbilt School of Medicine, Nashville, Tennessee. · Pubmed 26539793
  • Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. · Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People's Republic of China. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 26500061
2015
  • Beth Israel Deaconess Medical Center, Boston, MA · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25559817
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Pubmed 26255198
  • Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139; · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Hematology/Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114; · Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114. · Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; · Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; · Pubmed 26578779
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1257, Boston, MA, 02215, USA. · Harvard Medical School, Boston, MA, USA. · Department of Biostatistics and Computation Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Yawkey 1257, Boston, MA, 02215, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Belfer Institute for Applied Cancer Sciences, Dana-Farber Cancer Institute, Boston, MA, USA. · Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA. · Pubmed 26123926
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Brigham and Women's Hospital, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Stanford Health Care, Stanford, CA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Brigham and Women's Hospital, Boston, MA, USA. · Harvard Medical School, Boston, MA, USA. · Brigham and Women's Hospital, 75 Francis Street, PBB-A4, Boston, MA, 02115, USA. · Pubmed 26420402
  • Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Memorial Sloan Kettering Cancer Center, New York, New York, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Massachusetts General Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Memorial Sloan Kettering Cancer Center, New York, New York, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Massachusetts General Hospital, Boston, Massachusetts, USA · Pubmed 26240134
  • International Breast Cancer Study Group, University of Sydney, Sydney, Australia. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · International Breast Cancer Study Group, Program of Breast Health (Senology), European Institute of Oncology, Milan, Italy · International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, USA. · Department of Surgery and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria. · Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium. · Breast Center, Kantonsspital St Gallen, St Gallen. · Tumor and Breast Center ZeTuP, St Gallen, Switzerland. · Pubmed 25939896
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. · Department of Medical Oncology, Mayo Clinic, Rochester, MN, USA. · Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA, USA. · Division of Medical Oncology, University of Colorado, Aurora, CO, USA. · Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 25930247
  • Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 25893416
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of, Medical Oncology, Department of Medicine, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Medical Oncology, Baptist Cancer Center, Memphis, Tennessee. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25757412
  • Dana-Farber Cancer Institute, Boston, MA. Electronic address: · Brigham and Women's Hospital, Boston, MA. · Case Comprehensive Cancer Center, Cleveland, OH. · Mt Kisco Medical Group, Mt Kisco, NY. · Dana-Farber Cancer Institute, Boston, MA. · Massachusetts General Hospital, Boston, MA. · Beth Israel Deaconess Medical Center, Boston, MA. · Pubmed 25205424
  • Dana-Farber Cancer Institute, Boston, MA · MD Anderson Cancer Center, Houston, TX. · Duke University, Durham, NC. · Memorial Sloan Kettering Cancer Center, New York, NY. · Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25512457
2014
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, Arome, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, DE, USA. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · Advanced BC.org, New York, USA. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, DE, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25244983
  • Department of Oncology, Mayo Clinic, Rochester, MN. Electronic address: · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA. · Tufts University School of Medicine, Boston, MA. · Division of Medical Oncology, University of Colorado Denver, Denver, CO. · Pubmed 24970714
  • University Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain · Beth Israel Deaconess Medical Center, Boston. · Massachusetts General Hospital, Boston. · University Hospital Vall d'Hebron and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. · AstraZeneca, Wilmington, USA. · AstraZeneca, Macclesfield, UK. · Dana-Farber Cancer Institute, Boston. · Memorial Sloan-Kettering Cancer Center, New York, USA. · Pubmed 24827126
  • 1] Departments of Bioengineering and Therapeutic Sciences, University of California at San Francisco, San Francisco, CA, USA [2] Institute for Human Genetics, University of California at San Francisco, San Francisco, CA, USA. · 1] Institute for Human Genetics, University of California at San Francisco, San Francisco, CA, USA [2] Department of Epidemiology and Biostatistics, University of California at San Francisco, San Francisco, CA, USA. · 1] Division of Rheumatology, Immunology, and Allergy, Division of Genetics, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA [2] Medical and Population Genetics Program, Chemical Biology Program, Broad Institute, Cambridge, MA, USA. · Center for Systems Genomics, Department of Biochemistry and Molecular Biology, The Pennsylvania State University, Eberly College of Science, The Huck Institutes of the Life Sciences, University Park, PA, USA. · Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Laboratory of Molecular Medicine, University of Tokyo, Tokyo, Japan. · Center for Integrative Medical Sciences, Riken Center, Yokohama, Japan. · 1] Laboratory of Molecular Medicine, University of Tokyo, Tokyo, Japan [2] Center for Integrative Medical Sciences, Riken Center, Yokohama, Japan [3] Department of Medicine, University of Chicago, Chicago, IL, USA. · Department of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. · Department of Medicine, University of Chicago, Chicago, IL, USA. · Pubmed 24513692
  • European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal · European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland. · Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy. · Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA. · Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal. · University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver, Canada. · Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA. · APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France. · Program of Breast Health, European Institute of Oncology, Milan, Italy. · Brustzentrum der Universität München, Munich, Denmark. · Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia. · Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Europa Donna Cyprus, Nicosa, Cyprus. · AdvancedBC.org, New York. · University of Michigan Medical School and School of Public Health, Ann Arbor, USA. · Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Brussels, Belgium. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Indiana University Medical CTR, Indianapolis, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland. · Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK. · Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Pubmed 25234545
  • 1] Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035 Barcelona, Spain [2] Department of Medicine, Universitat Autònoma de Barcelona, 08193 Barcelona, Spain. · Department of Medical Oncology and Department of Pathology, Hospital Clínico Universitario de Valencia, 46010 Valencia, Spain. · 1] Department of Medical Oncology, Hospital del Mar, IMIM, 08003 Barcelona, Spain [2] Department of Medical Oncology, Universitat Pompeu Fabra (UPF), 08002 Barcelona, Spain. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA. · Department of Medical Oncology, Hospital Virgen de la Salud, 45004 Toledo, Spain. · 1] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA [2] Department of Genetics, University of North Carolina, Chapel Hill, NC 27519, USA. · Department of Medical Oncology, Complexo Hospitalario Universitario de A Coruña, 15002 A Coruña, Spain. · Department of Medical Oncology, Onkologikoa, 20014 San Sebastián, Spain. · Department of Medical Oncology, Consorci Sanitari de Terrassa, 08225 Barcelona, Spain. · Department of Medical Oncology, Corporació Sanitària Parc Taulí, 08208 Sabadell, Spain. · Department of Medical Oncology and Department of Pathology, Hospital Universitario Virgen de la Victoria, 29010 Malaga, Spain. · Department of Medical Oncology, Hospital General de Elche, 03203 Alicante, Spain. · Department of Medical Oncology, Instituto Valenciano de Oncología (IVO), 46009 Valencia, Spain. · Department of Medical Oncology, Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain. · Department of Medical Oncology, Hospital Universitario La Fe, 46026 Valencia, Spain. · Department of Medical Oncology, Hospital San Camilo, 28006 Madrid, Spain. · Translational Genomics Group, Vall d'Hebron Institute of Oncology (VHIO), Pg Vall d'Hebron, 119-129, 08035 Barcelona, Spain. · Alliance Statistical and Data Center, Duke University, Durham, NC 27708, USA. · Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA. · ProHEALTH Care Associates, LLP, Lake Success, NY 11803, USA. · Department of Oncology, Washington University, St. Louis, MO 63130, USA. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. · Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · GEICAM (Spanish Breast Cancer Research Group), 28700 Madrid, Spain. · 1] GEICAM (Spanish Breast Cancer Research Group), 28700 Madrid, Spain [2] Department of Medical Oncology, Instituto de Investigación Sanitaria Hospital Universitario Gregorio Marañón, Facultad de Medicina, Universidad Complutense, 28007 Madrid, Spain. · 1] Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27519, USA [2] Department of Genetics, University of North Carolina, Chapel Hill, NC 27519, USA [3] Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27519, USA. · Pubmed 25101563
  • University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC 27599, USA. Electronic address: · Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 24529559
2013
  • Department of Oncology, Georgetown University Medical Center and Lombardi Cancer Center, Cancer Prevention and Control Program, Washington, DC, USA. Electronic address: · Department of Oncology, Georgetown University Medical Center and Lombardi Cancer Center, Cancer Prevention and Control Program, Washington, DC, USA. · Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University Medical Center and Lombardi Cancer Center, Washington, DC, USA. · Department of Medical Oncology & Therapeutics Research, City of Hope, LA, CA, USA. · Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, NC, USA. · Department of Medicine, Georgetown University School of Medicine and Lombardi Cancer Center, Breast Cancer Program, Washington, DC, USA. · Department of Biostatistics and Bioinformatics, Duke University Medical Center, and Cancer and Leukemia Group B Statistical Center, Durham, NC, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Department of Medicine and Center for the Study of Aging and Human Development, Duke University, Durham, NC, USA. · Department of Medicine, University of North Carolina, Chapel Hill, NC, USA. · Pubmed 24472479
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 23313328
2018
  • From the Peter MacCallum Cancer Centre, St. Vincent's Hospital, University of Melbourne, Melbourne, VIC, and Breast Cancer Trials Australia and New Zealand, University of Newcastle, Newcastle, NSW (P.A.F.), and the University of Sydney, Sydney (A.S.C.) - all in Australia; the Institute of Oncology of Southern Switzerland, Ospedale San Giovanni, Bellinzona (O.P.), Breast Cancer St. Gallen, St. Gallen (T.R.), and the International Breast Cancer Study Group Coordinating Center (R.M., M.R.-P., B.R., A.S.C.), University Hospital Inselspital (M.R.-P.), Bern - all in Switzerland; the University of Chicago Medical Center, Chicago (G.F.F.); the University of Calgary, Calgary, AB, Canada (B.A.W.); the Division of Medical Senology, European Institute of Oncology (M.C.), and the European Institute of Oncology and International Breast Cancer Study Group (A.G.), Milan, Ospedale Papa Giovanni XXIII, Bergamo (C.T.), Azienda Socio Sanitaria Territoriale Sette Laghi-Ospedale di Circolo and Fondazione Macchi, Varese (G.P.), Medical Oncology and Cancer Prevention, IRCCS, National Cancer Institute, Aviano (F.P., S.S.), the Department of Medicine, School of Medical Oncology, University of Udine, Udine (F.P.), Salvatore Maugeri Foundation, Pavia (L.P.), and the Hospital of Prato-Azienda Unità Sanitaria Locale Toscana Centro, Prato (A.D.L.) - all in Italy; the National Institute of Oncology, Budapest, Hungary (I.L.); Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru (H.L.G.); University Hospital 12 de Octubre, Madrid (E.C.), Vall d'Hebron Institute of Oncology and Vall d'Hebron University Hospital, Barcelona (M.B.), and Instituto Valenciano de Oncologia, Valencia (M.A.C.) - all in Spain; the Susan F. Smith Center for Women's Cancers (H.J.B., E.P.W.) and the International Breast Cancer Study Group Statistical Center, Department of Biostatistics and Computational Biology (R.D.G., M.M.R.), Dana-Farber Cancer Institute, Harvard Medical School, the Harvard T.H. Chan School of Public Health, and Frontier Science and Technology Research Foundation (R.D.G.) - all in Boston; Institut Bergonié Comprehensive Cancer Center, Université de Bordeaux, Bordeaux, France (H.R.B., M.D.); the Angeles Clinic and Research Institute, Santa Monica, CA (S.M.); Massey Cancer Center, Virginia Commonwealth University School of Medicine, Richmond (C.E.G.); Mayo Clinic, Rochester, MN (M.P.G., J.N.I.); Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore (V.S.); Fred Hutchinson Cancer Research Center, University of Washington, Seattle (N.E.D.); Weston Park Hospital, Sheffield, United Kingdom (R.C.); and the Department of Obstetrics and Gynecology, University Medical Center, Regensburg, Germany (S.B.). · Pubmed 29863451
2017
  • Matthew J. Ellis and Chad J. Creighton, Baylor College of Medicine; Gildy Babiera and Kelly Hunt, MD Anderson Cancer Center, Houston; Gary Unzeitig, Doctor's Hospital of Laredo, Laredo; Marilyn Leitch, University of Texas Southwestern Campus, Dallas, TX; Vera J. Suman, Mayo Clinic, Rochester MN; Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Katherine DeSchryver, Erika Crouch, Amy Brink, Mark Watson, Jingqin Luo, Yu Tao, Cynthia X. Ma, and D. Craig Allred, Washington University School of Medicine, St Louis; Timothy Pluard, St Lukes Hospital, Kansas City, MO; Michael Barnes, Roche Diagnostics, Mountain View; Laura Esserman, University of California San Francisco, San Francisco, CA; Mitchell Dowsett, Royal Marsden Hospital, London, UK; G. Thomas Budd, Cleveland Clinic; Paula Silverman, Case Western Reserve University, Cleveland OH; Eric Winer, Dana-Farber Cancer Institute, Boston MA; Lisa Carey, University of North Carolina, Chapel Hill; David Ota, Duke University, Durham, NC; Pat Whitworth, Nashville Breast Center, Nashville, TN; J. Michael Guenther, St Elizabeth Medical Center, Edgewood, KY; Zoneddy Dayao, University of New Mexico, Albuquerque, NM; and John A. Olson Jr, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, MD. · Pubmed 28045625
  • From Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Academic Unit of Medical Oncology, IRCCS San Martino University Hospital - IST National Cancer Research Institute, Genoa, Italy; Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts; and Department of Medical Oncology and Unit INSERM 981, Institut Gustave Roussy, Paris, France. · Pubmed 28275032
  • Rachel A. Freedman, Eric P. Winer, and Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Jared C. Foster, Drew K. Seisler, Jacqueline M. Lafky, and Aminah Jatoi, Mayo Clinic; Jared C. Foster and Drew K. Seisler, Mayo Cancer Center, Rochester, MN; Hyman B. Muss and Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Harvey J. Cohen, Constance Cirrincione, and Gretchen Kimmick, Duke University, Durham, NC; Jeanne Mandelblatt, Georgetown University, Washington, DC; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL; and Arti Hurria, City of Hope, Duarte, CA. · Pubmed 27992272
2016
  • Harold J. Burstein and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester, Rochester, NY; Thomas A. Buchholz and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, BC; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Alexander J. Solky, Interlakes Oncology and Hematology PC, Rochester, NY; Vered Stearns, Johns Hopkins, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Harold J. Burstein and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester, Rochester, NY; Thomas A. Buchholz and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, BC; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Alexander J. Solky, Interlakes Oncology and Hematology PC, Rochester, NY; Vered Stearns, Johns Hopkins, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Pubmed 26884586
  • From the University of Texas M.D. Anderson Cancer Center, Houston (G.N.H.), and Texas Oncology-Baylor Charles A. Sammons Cancer Center and the U.S. Oncology Network, Dallas (J.O.) - all in Texas; Davidoff Center, Rabin Medical Center, Tel Aviv University, Tel Aviv (S.M.S.), and Sheba Medical Center, Ramat Gan (S.P.-S.) - both in Israel; the Sarah Cannon Research Institute (H.A.B., D.Y.), Vanderbilt-Ingram Cancer Center (C.L.A.), and Tennessee Oncology (D.Y.) - all in Nashville; National Cancer Center Singapore, Singapore (Y.-S.Y.); Netherlands Cancer Institute and BOOG Study Center, Amsterdam (G.S.S.); Institut de Cancérologie de l'Ouest/René Gauducheau, Saint-Herblain (M.C.), Institut Gustave Roussy, Université Paris Sud, Villejuif (F.A.), University Hospital of Besançon, Besançon (C.V.), and Centre Léon Bérard, Lyon (T.B.) - all in France; Duke University Medical Center, Durham, NC (K.L.B.); Dana-Farber Cancer Institute, Boston (E.P.W.); University of Ulm, Ulm (W.J.), Onkologische Praxis, Velbert (A.N.), University of Tübingen, Tübingen (E.-M.G.), and Joint Practice for Interdisciplinary Oncology and Hematology, Freiburg (N.M.) - all in Germany; Tom Baker Cancer Centre, Calgary, AB, Canada (S.V.); University of Padua and Istituto Oncologico Veneto, Istituto di Ricovero e Cura a Carattere Scientifico, Padua, Italy (P.C.); Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh (D.A.C.); Masaryk Memorial Cancer Institute, Brno, Czech Republic (K.P.); Florida Cancer Specialists-Sarah Cannon Research Institute, Fort Myers (L.L.H.); Breast Cancer Research Centre-Western Australia and Curtin University, Perth, Australia (A.C.); Department of Oncology, Vejle Hospital, Vejle, Denmark (E.J.); Arkhangelsk Clinical Oncology Dispensary, Arkhangelsk, Russia (O.B.); Hospital Universitario Virgen de la Victoria, Institute of Biomedical Research in Málaga, Málaga, Spain (E.A.); Oslo University Hospital, Oslo (E.W.); Virginia Cancer Specialists, Arlington (A.M.F.); Taipei Veterans General Hospital, National Yang-Ming University, Taipei, Taiwan (L.-M.T.); Rainier Hematology-Oncology, Northwest Medical Specialties, Puyallup, WA (S.B.); Novartis Pharmaceuticals, East Hanover, NJ (F.X., M.M., C.G., S.H.); and Novartis Pharma, Basel, Switzerland (F.S.). · Pubmed 27717303
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
  • Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 27138575
  • Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN. · Rachel A. Freedman, Rebecca S. Gelman, Christina Herold, Nicole Ryabin, Sarah Farooq, Elizabeth Lawler, Ian E. Krop, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital; Alarice Lowe and Nathalie Y.R. Agar, Brigham and Women's Hospital, Boston, MA; Jeffrey S. Wefel, Kenneth R. Hess, and Nuhad Ibrahim, The University of Texas MD Anderson Cancer Center; Polly A. Niravath and Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; Michelle E. Melisko, University of California, San Francisco, San Francisco, CA; Roisin M. Connolly and Antonio C. Wolff, Johns Hopkins University, Baltimore, MD; Catherine H. Van Poznak, University of Michigan, Ann Arbor, MI; Shannon L. Puhalla, University of Pittsburgh Cancer Institute and Magee-Women's Hospital, Pittsburgh, PA; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; and Minetta C. Liu, Mayo Clinic, Rochester, MN. · Pubmed 26834058
  • Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Pubmed 26527775
  • Ann H. Partridge, Melissa E. Hughes, Erica T. Warner, Eric P. Winer, Jane C. Weeks, and Rulla M. Tamimi, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Erica T. Warner, Harvard T.H. Chan School of Public Health, Boston, MA; Rebecca A. Ottesen and Joyce C. Niland, City of Hope Comprehensive Cancer Center, Duarte; and Douglas W. Blayney, Stanford Cancer Institute, Palo Alto, CA; Yu-Ning Wong, Fox Chase Cancer Center, Philadelphia, PA; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Ann H. Partridge, Melissa E. Hughes, Erica T. Warner, Eric P. Winer, Jane C. Weeks, and Rulla M. Tamimi, Dana-Farber Cancer Institute and Brigham and Women's Hospital; Erica T. Warner, Harvard T.H. Chan School of Public Health, Boston, MA; Rebecca A. Ottesen and Joyce C. Niland, City of Hope Comprehensive Cancer Center, Duarte; and Douglas W. Blayney, Stanford Cancer Institute, Palo Alto, CA; Yu-Ning Wong, Fox Chase Cancer Center, Philadelphia, PA; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Richard L. Theriault, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 27480155
2015
  • *Department of Surgery, Brigham and Women's Hospital, Boston, MA †Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC ‡Department of Medical Oncology Women and Infants Hospital and Alpert Medical School of Brown University, Providence, RI §Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX ¶Department of Medical Oncology, Maine Center for Cancer Medicine, Scarborough, ME ∥Department of Medical Oncology, City of Hope Medical Center, Los Angeles, CA **Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY ††Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and ‡‡Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. · Pubmed 26222764
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Pubmed 25847936
  • Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD). · Departments of Breast Medical Oncology (AMGA, SL, SMT), Systems Biology (AMGA, GBM), Biostatistics (HC, YL, K-AD), Experimental Therapeutics (KSC), Investigational Cancer Therapeutics (AA, ET, SPP, VV-B, FMB), Pathology (AAS) and Surgical Oncology (FMB), The University of Texas MD Anderson Cancer Center, Houston, TX; Division of Hematology-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA (IK, EPW); Division of Hematology-Oncology, University of California, San Diego, CA (RK); Cancer Therapy Evaluation Program, NIH/National Cancer Institute, Rockville, MD (LAD). · Pubmed 25688104
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • Dana-Farber Cancer Institute, 450 Brookline Ave., Boston, MA, 02215, USA, · Pubmed 25537644
  • William M. Sikov, Miriam Hospital and Alpert Medical School of Brown University, Providence, RI; Donald A. Berry, University of Texas MD Anderson Cancer Center, Houston, TX; Charles M. Perou and Lisa A. Carey, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill; Constance T. Cirrincione, Alliance Statistical Center, Durham; Charles S. Kuzma, Southeast Cancer Control Consortium, Winston-Salem, NC; Baljit Singh, New York University Medical Center; Elisa R. Port, Mount Sinai Medical Center; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Sara M. Tolaney, Mehra Golshan, Jennifer R. Bellon, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Timothy J. Pluard, Washington University-St Louis Medical Center, St Louis, MO; George Somlo, City of Hope Comprehensive Cancer Center, Duarte; Deborah Collyar, Patient Advocates in Research, Danville, CA; and Olwen M. Hahn, University of Chicago Medical Center, Chicago, IL. · William M. Sikov, Miriam Hospital and Alpert Medical School of Brown University, Providence, RI; Donald A. Berry, University of Texas MD Anderson Cancer Center, Houston, TX; Charles M. Perou and Lisa A. Carey, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill; Constance T. Cirrincione, Alliance Statistical Center, Durham; Charles S. Kuzma, Southeast Cancer Control Consortium, Winston-Salem, NC; Baljit Singh, New York University Medical Center; Elisa R. Port, Mount Sinai Medical Center; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Sara M. Tolaney, Mehra Golshan, Jennifer R. Bellon, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Timothy J. Pluard, Washington University-St Louis Medical Center, St Louis, MO; George Somlo, City of Hope Comprehensive Cancer Center, Duarte; Deborah Collyar, Patient Advocates in Research, Danville, CA; and Olwen M. Hahn, University of Chicago Medical Center, Chicago, IL. · Pubmed 25092775
  • Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Otto Metzger Filho, Anita Giobbie-Hurder, and Eric P. Winer, Dana-Farber Cancer Institute; Richard D. Gelber and Meredith M. Regan, Harvard Medical School; Karen N. Price, Frontier Science and Technology Research, Boston, MA; Elizabeth Mallon, Southern General Hospital; Barry Gusterson, Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom; Giuseppe Viale, European Institute of Oncology and University of Milan; Marco Colleoni and Aron Goldhirsch, European Institute of Oncology, Milan, Italy; Beat Thürlimann, Kantonsspital, St. Gallen, and Swiss Group for Clinical Cancer Research, Bern, Switzerland; Bent Ejlertsen, Rigshospitalet, Copenhagen, Denmark; Marc Debled, Institut Bergoniié, Bordeaux, France; and Alan S. Coates, International Breast Cancer Study Group, Bern, Switzerland, and University of Sydney, Sydney, Australia. · Pubmed 26215945
  • Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB). · Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB). · Pubmed 26113580
  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; University Hospitals Case Medical Center, Cleveland, Ohio, USA; Harvard Medical School, Boston, Massachusetts, USA; Mayo Clinic, Rochester, Minnesota, USA; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Colorado Cancer Center, Aurora, Colorado, USA; Oregon Health & Science University, Portland, Oregon, USA; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA · Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Geisel School of Medicine at Dartmouth and Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; University Hospitals Case Medical Center, Cleveland, Ohio, USA; Harvard Medical School, Boston, Massachusetts, USA; Mayo Clinic, Rochester, Minnesota, USA; Massachusetts General Hospital, Boston, Massachusetts, USA; University of Colorado Cancer Center, Aurora, Colorado, USA; Oregon Health & Science University, Portland, Oregon, USA; Sunnybrook Odette Cancer Centre, Toronto, Ontario, Canada; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. · Pubmed 26025931
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 26022349
  • Erica T. Warner and Rulla M. Tamimi, Harvard School of Public Health; Erica T. Warner, Rulla M. Tamimi, Melissa E. Hughes, Eric P. Winer, Jane C. Weeks, and Ann H. Partridge, Brigham and Women's Hospital; Melissa E. Hughes, Eric P. Winer, Jane C. Weeks, and Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Rebecca A. Ottesen and Joyce C. Niland, City of Hope Comprehensive Cancer Center, Duarte; Douglas W. Blayney, Stanford University Cancer Center, Palo Alto, CA; Yu-Ning Wong, Fox Chase Cancer Center, Philadelphia, PA; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Erica T. Warner and Rulla M. Tamimi, Harvard School of Public Health; Erica T. Warner, Rulla M. Tamimi, Melissa E. Hughes, Eric P. Winer, Jane C. Weeks, and Ann H. Partridge, Brigham and Women's Hospital; Melissa E. Hughes, Eric P. Winer, Jane C. Weeks, and Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Rebecca A. Ottesen and Joyce C. Niland, City of Hope Comprehensive Cancer Center, Duarte; Douglas W. Blayney, Stanford University Cancer Center, Palo Alto, CA; Yu-Ning Wong, Fox Chase Cancer Center, Philadelphia, PA; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 25964252
  • Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA. · Edith A. Perez, E. Aubrey Thompson, Yan W. Asmann, and Xochiquetzal J. Geiger, Mayo Clinic, Jacksonville, FL; Karla V. Ballman, S. Keith Anderson, Krishna R. Kalari, Jeanette E. Eckel-Passow, Kathleen S. Tenner, Jin Jen, Beiyun Chen, Robert B. Jenkins, and Monica M. Reinholz, Mayo Clinic, Rochester, MN; Amylou C. Dueck, and Ann E. McCullough, Mayo Clinic, Scottsdale, AZ; Jian-Bing Fan, Illumina, San Diego, CA; George W. Sledge, Stanford School of Medicine, Palo Alto, CA; Eric P. Winer, Harvard Medical School, Boston, MA; and Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA. · Pubmed 25605861
2014
  • Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester; Alexander J. Solky, Interlakes Onc and Hem PC, Rochester; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas A. Buchholz, Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston; Diana Rowden, Dallas, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Vered Stearns, Johns Hopkins School of Medicine, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester; Alexander J. Solky, Interlakes Onc and Hem PC, Rochester; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas A. Buchholz, Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston; Diana Rowden, Dallas, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Vered Stearns, Johns Hopkins School of Medicine, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Pubmed 24868023
  • Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando; Edith A. Perez, Mayo Clinic, Jacksonville; Jennifer Levinson, Ponte Vedra Beach, FL; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Ian Krop, Eric P. Winter, and Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799487
  • Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Ian Krop, Nancy U. Lin, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jennifer Levinson, Ponte Vedra Beach; Edith A. Perez, Mayo Clinic, Jacksonville; Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando, FL; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799465
  • Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology; Joyce O'Shaughnessy, US Oncology, Dallas; Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX; Lee Schwartzberg, Accelerated Community Oncology Research Network; Lee Schwartzberg, The West Clinic, Memphis; Denise A. Yardley, Sarah Cannon Research Institute; Denise A. Yardley, Tennessee Oncology, Nashville, TN; Michael A. Danso, US Oncology; Michael A. Danso, Virginia Oncology Associates, Norfolk; Nicholas Robert, Virginia Cancer Specialists, Fairfax; Paul Richards, Blue Ridge Cancer Care, Salem, VA; Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco; Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA; Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles; Richard S. Finn, Translational Research in Oncology, Los Angeles, CA; Marcus Neubauer, Kansas City Cancer City, Overland Park, KS; Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA; Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge; and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Joyce O'Shaughnessy, Baylor Charles A. Sammons Cancer Center, Texas Oncology; Joyce O'Shaughnessy, US Oncology, Dallas; Beth Hellerstedt Texas Oncology-Round Rock, Austin, TX; Lee Schwartzberg, Accelerated Community Oncology Research Network; Lee Schwartzberg, The West Clinic, Memphis; Denise A. Yardley, Sarah Cannon Research Institute; Denise A. Yardley, Tennessee Oncology, Nashville, TN; Michael A. Danso, US Oncology; Michael A. Danso, Virginia Oncology Associates, Norfolk; Nicholas Robert, Virginia Cancer Specialists, Fairfax; Paul Richards, Blue Ridge Cancer Care, Salem, VA; Kathy D. Miller, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN; Hope S. Rugo, University of California, San Francisco Comprehensive Cancer Center, San Francisco; Robert W. Carlson, Stanford Comprehensive Cancer Center, Palo Alto, CA; Richard S. Finn, Geffen School of Medicine at University of California, Los Angeles; Richard S. Finn, Translational Research in Oncology, Los Angeles, CA; Marcus Neubauer, Kansas City Cancer City, Overland Park, KS; Mansoor Saleh, Georgia Cancer Specialists, Sandy Springs, GA; Jennifer M. Specht, University of Washington, Seattle Cancer Care Alliance, Seattle, WA; Eric Charpentier, Ignacio Garcia-Ribas, Sanofi, Cambridge; and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 25349301
  • Harold J. Burstein, William T. Barry, Sara M. Tolaney, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Constance T. Cirrincione, Duke University Alliance Statistics and Data Center; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; Helen K. Chew, University of California, Davis, Davis, CA; Diana E. Lake and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Cynthia Ma, Washington University School of Medicine, St Louis, MO. · Harold J. Burstein, William T. Barry, Sara M. Tolaney, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Constance T. Cirrincione, Duke University Alliance Statistics and Data Center; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; Helen K. Chew, University of California, Davis, Davis, CA; Diana E. Lake and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Cynthia Ma, Washington University School of Medicine, St Louis, MO. · Pubmed 25348000
  • Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA, · Pubmed 24756187
  • Ingrid A. Mayer, Vandana G. Abramson, Justin M. Balko, María Gabriela Kuba, Melinda E. Sanders, and Carlos L. Arteaga, Vanderbilt University, Nashville, TN; Steven J. Isakoff, Massachusetts General Hospital, Boston, MA; Andres Forero, University of Alabama, Birmingham, AL; Jeffrey T. Yap, Huntsman Cancer Institute, Salt Lake City, UT; Annick D. Van den Abbeele and Eric Winer, Dana-Farber Cancer Institute, Boston, MA; Yisheng Li, MD Anderson Cancer Center, Houston, TX; and Lewis C. Cantley, Weill Cornell Medical College, New York, NY. · Pubmed 24663045
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24464780
  • Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Edith A. Perez, Gerardo Colon-Otero, the Mayo Clinic, Jacksonville; Eleftherios Mamounas, University of Florida Health Cancer Center-Orlando Health, Orlando, FL; Edward H. Romond, University of Kentucky, Lexington, KY; Vera J. Suman, Mayo Clinic, Rochester, MN; Jong-Hyeon Jeong, Priya Rastogi, University of Pittsburgh; Nancy E. Davidson, University of Pittsburgh Cancer Institute; Norman Wolmark, Allegheny General Hospital, Pittsburgh, PA; George Sledge, Stanford University School of Medicine, Stanford; Silvana Martino, The Angeles Clinic and Research Institute, Santa Monica, CA; Charles E. Geyer Jr, Virginia Commonwealth University Massey Cancer Center, Richmond, VA; Julie Gralow, University of Washington/Seattle Cancer Care Alliance, Seattle, WA; Sandra M. Swain, MedStar Washington Hospital Center, Washington, DC; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jo Anne Zujewski, National Institutes of Health, Rockville, MD. · Pubmed 25332249
  • Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Dana Farber Cancer Institute, Boston, MA; City of Hope National Medical Center, Duarte, CA; and Memorial Sloan Kettering Cancer Center, New York, NY · Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Dana Farber Cancer Institute, Boston, MA; City of Hope National Medical Center, Duarte, CA; and Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 25074878
  • Lawrence N. Shulman, Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Donald A. Berry, MD Anderson Cancer Center, Houston, TX; Constance T. Cirrincione, Gretchen Kimmick, Duke University Medical Center, Durham; Hyman Muss, University of North Carolina at Chapel Hill, Chapel Hill, NC; Heather P. Becker, University of Chicago, Chicago, IL; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Ruth O'Regan, Emory University, Atlanta, GA; Silvana Martino, The Angeles Clinic and Research Institute, Los Angeles, CA; Charles L. Shapiro, The James Cancer Center, Ohio State University, Columbus, OH; Charles J. Schneider, Christiana Healthcare Services, Wilmington, DE; Larry Norton, Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY. · Lawrence N. Shulman, Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Donald A. Berry, MD Anderson Cancer Center, Houston, TX; Constance T. Cirrincione, Gretchen Kimmick, Duke University Medical Center, Durham; Hyman Muss, University of North Carolina at Chapel Hill, Chapel Hill, NC; Heather P. Becker, University of Chicago, Chicago, IL; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Ruth O'Regan, Emory University, Atlanta, GA; Silvana Martino, The Angeles Clinic and Research Institute, Los Angeles, CA; Charles L. Shapiro, The James Cancer Center, Ohio State University, Columbus, OH; Charles J. Schneider, Christiana Healthcare Services, Wilmington, DE; Larry Norton, Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24934787
  • Vanessa B. Sheppard, Leigh Anne Faul, George Luta, Jonathan D. Clapp, Judy Huei-yu Wang, Claudine Isaacs, Michelle Tallarico, and Jeanne S. Mandelblatt, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Rachel L. Yung and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Gretchen Kimmick, William T. Barry, Brandelyn N. Pitcher, and Harvey J. Cohen, Duke University Medical Center; William T. Barry and Brandelyn N. Pitcher, Cancer and Leukemia Group B Statistical Center, Durham; Hyman B. Muss, University of North Carolina Chapel Hill, Chapel Hill, NC; Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Arti Hurria, City of Hope, Los Angeles, CA. · Vanessa B. Sheppard, Leigh Anne Faul, George Luta, Jonathan D. Clapp, Judy Huei-yu Wang, Claudine Isaacs, Michelle Tallarico, and Jeanne S. Mandelblatt, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Rachel L. Yung and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Gretchen Kimmick, William T. Barry, Brandelyn N. Pitcher, and Harvey J. Cohen, Duke University Medical Center; William T. Barry and Brandelyn N. Pitcher, Cancer and Leukemia Group B Statistical Center, Durham; Hyman B. Muss, University of North Carolina Chapel Hill, Chapel Hill, NC; Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Arti Hurria, City of Hope, Los Angeles, CA. · Pubmed 24934786
  • Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Jeffrey B. Smerage, Anne F. Schott, and Daniel F. Hayes, University of Michigan Comprehensive Cancer Center, Ann Arbor; Gordan Srkalovic, Sparrow Regional Cancer Center, Lansing; Sheela Tejwani, Henry Ford Hospital, Detroit, MI; William E. Barlow and Danika L. Lew, SWOG Statistical Center; Julie R. Gralow, Seattle Cancer Care Alliance, Seattle, WA; Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston, TX; Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Brian Leyland-Jones, Avera Cancer Institute, Sioux Falls, SD; Mark A. O'Rourke, Greenville Health System Cancer Institute/Greenville Community Clinical Oncology Program, Greenville, SC; Gerald V. Doyle, Immunicon, Huntingdon Valley, PA; and Robert B. Livingston, University of Arizona Cancer Center, Tucson, AZ. · Pubmed 24888818
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute; Beverly Moy, Massachusetts General Hospital, Boston, MA; Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal; Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte; Hope S. Rugo, University of California, San Francisco, San Francisco, CA; Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY; Stephen B. Edge, Baptist Cancer Center, Memphis, TN; and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • Ines Vaz-Luis, Nancy U. Lin, Eric P. Winer, and Rachel A. Freedman, Dana-Farber Cancer Institute; Nancy L. Keating, Harvard Medical School; Nancy L. Keating and Huichuan Lii, Brigham and Women's Hospital, Boston, MA; and Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal. · Pubmed 24516021
  • From the aDepartment of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, and bDepartment of Medical Oncology, The Ohio State University College of Medicine, Columbus, Ohio. · Pubmed 24453294
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24347383
  • Authors' Affiliation: Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 24135146
  • Psychosocial Oncology & Palliative Care, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, USA. · Pubmed 24700635
2013
  • Department of Medical Oncology, Dana-Farber/Brigham and Women's Cancer Center, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 23601761
  • Authors' Affiliation: Dana-Farber Cancer Institute, Boston, Massachusetts. · Pubmed 23942091
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23425944
  • Department of Medical Oncology, Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA 02215 USA. · Pubmed 23022997
  • Harvard Medical School, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA, · Pubmed 24197661
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA, · Pubmed 24062210
  • Brigham and Women's Hopspital, Boston, MA, USA, · Pubmed 24026859
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Pubmed 23868188
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23810467
  • Department of Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, MA 02115, USA. · Pubmed 23645007
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 24113744
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Breast Oncology Center, Boston, MA 02215, USA. · Pubmed 23829891
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02115, USA. · Pubmed 23752109
  • Harvard Medical School, Boston, MA, USA. · Pubmed 23690420
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23681403
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA. · Pubmed 23663229
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA. · Pubmed 23568001
  • Deparment of Medical Oncology, Dana-Farber Cancer Institute, Boston. MA02215, USA. · Pubmed 23493137
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 23349386
  • Harvard School of Public Health, Boston, MA, USA. · Pubmed 23132765
  • Division of General Internal Medicine, Brigham and Women's Hospital, and Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts 02115, USA. · Pubmed 22833148
  • Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. · Pubmed 22812628
  • Massachusetts General Hospital, Boston, MA. · Pubmed 24190113
2012
  • Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 22957400
  • Dana-Farber Cancer Institute and Brigham and Women's Hospital-Harvard Medical School, Boston, MA 02215, USA. · Pubmed 23277772
  • Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Ave, Boston, MA 02215, USA. · Pubmed 23001754
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Pubmed 22826271
  • Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. · Pubmed 22767584
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston MA 02215, USA. · Pubmed 22649126
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 22418700
  • Department of Epidemiology, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115, USA. · Pubmed 23099438
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Pubmed 22791365
  • Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Pubmed 22614986
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02115, USA. · Pubmed 22554997
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Pubmed 22544643
  • Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 22444718
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 22225715
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02115, USA. · Pubmed 22162585
  • Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, USA. · Pubmed 22080245
  • Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. · Pubmed 22017599
  • Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 21881937
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Pubmed 21531783
2011
  • Dana-Farher Cancer Institute, Division of Women's Cancers. 450 Brookline Ave, Boston, MA 02115, USA. · Pubmed 22015279
  • Division of Women's Cancers, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Pubmed 21706359
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Harvard Medical School, Boston, MA 02115, USA. · Pubmed 21697017
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 21300923
  • Harvard Medical School, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA. · Pubmed 20939011
  • Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 20882415
  • Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 20376555
2010
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 20625130
  • Harvard Medical School, Dana Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. · Pubmed 20034796
  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA. · Pubmed 20629579
  • Perinatal and Reproductive Psychiatry Program, Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA. · Pubmed 20581724
  • Dana-Farber Cancer Institute, 44 Binney Street, Boston, MA 02115, USA. · Pubmed 20554945
  • Dana-Farber Cancer Institute, 44 Binney St, Boston, MA 02115, USA. · Pubmed 20368559
  • Dana-Farber Cancer Institute, Department of Medical Oncology, Smith 209, 1 Jimmy Fund Way, Boston, MA 02115, USA. · Pubmed 20100965
  • Department of Health Care Policy, Harvard Medical School, 180 Longwood Avenue, Boston, MA 02115, USA. · Pubmed 19949856
2009
  • Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Mayer 224, Boston, MA 02115, USA. · Pubmed 19294501
  • Dana-Farber Cancer Institute, Boston, USA. · Pubmed 19940286
  • Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115-6110, USA. · Pubmed 19792042
  • Division of General Internal Medicine, Department of Medicine, Brigham and Women's Hospital, 180 Longwood Avenue, Boston, MA 02115, USA. · Pubmed 19536008
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA. · Pubmed 19434504
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 19299239
Probable:    University of North Carolina Chapel Hill   Contact    
2016
  • From the Division of Hematology-Oncology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill (L.A.C.); and the Breast Oncology Program, Dana-Farber Cancer Institute, Boston (E.P.W.). · Pubmed 27406352
2017
  • Matthew J. Ellis and Chad J. Creighton, Baylor College of Medicine; Gildy Babiera and Kelly Hunt, MD Anderson Cancer Center, Houston; Gary Unzeitig, Doctor's Hospital of Laredo, Laredo; Marilyn Leitch, University of Texas Southwestern Campus, Dallas, TX; Vera J. Suman, Mayo Clinic, Rochester MN; Jeremy Hoog, Rodrigo Goncalves, Souzan Sanati, Katherine DeSchryver, Erika Crouch, Amy Brink, Mark Watson, Jingqin Luo, Yu Tao, Cynthia X. Ma, and D. Craig Allred, Washington University School of Medicine, St Louis; Timothy Pluard, St Lukes Hospital, Kansas City, MO; Michael Barnes, Roche Diagnostics, Mountain View; Laura Esserman, University of California San Francisco, San Francisco, CA; Mitchell Dowsett, Royal Marsden Hospital, London, UK; G. Thomas Budd, Cleveland Clinic; Paula Silverman, Case Western Reserve University, Cleveland OH; Eric Winer, Dana-Farber Cancer Institute, Boston MA; Lisa Carey, University of North Carolina, Chapel Hill; David Ota, Duke University, Durham, NC; Pat Whitworth, Nashville Breast Center, Nashville, TN; J. Michael Guenther, St Elizabeth Medical Center, Edgewood, KY; Zoneddy Dayao, University of New Mexico, Albuquerque, NM; and John A. Olson Jr, University of Maryland School of Medicine and Greenebaum Cancer Center, Baltimore, MD. · Pubmed 28045625
  • Rachel A. Freedman, Eric P. Winer, and Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Jared C. Foster, Drew K. Seisler, Jacqueline M. Lafky, and Aminah Jatoi, Mayo Clinic; Jared C. Foster and Drew K. Seisler, Mayo Cancer Center, Rochester, MN; Hyman B. Muss and Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Harvey J. Cohen, Constance Cirrincione, and Gretchen Kimmick, Duke University, Durham, NC; Jeanne Mandelblatt, Georgetown University, Washington, DC; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL; and Arti Hurria, City of Hope, Duarte, CA. · Pubmed 27992272
2016
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
  • Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 27138575
  • Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Pubmed 26527775
2015
  • *Department of Surgery, Brigham and Women's Hospital, Boston, MA †Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC ‡Department of Medical Oncology Women and Infants Hospital and Alpert Medical School of Brown University, Providence, RI §Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX ¶Department of Medical Oncology, Maine Center for Cancer Medicine, Scarborough, ME ∥Department of Medical Oncology, City of Hope Medical Center, Los Angeles, CA **Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY ††Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and ‡‡Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. · Pubmed 26222764
  • Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Nancy U. Lin, Hao Guo, Nicole Ryabin, Julie S. Najita, William T. Barry, Ian E. Krop, Eric P. Winer, and Annick D. Van den Abbeele, Dana-Farber Cancer Institute; Andrea L. Richardson and Annick D. Van den Abbeele, Brigham and Women's Hospital, Boston, MA; Jeffrey T. Yap, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Ingrid A. Mayer and Carlos L. Arteaga, Vanderbilt-Ingram Cancer Center, Nashville, TN; Carla I. Falkson, University of Alabama, Birmingham, AL; Timothy J. Hobday, Mayo Clinic, Rochester, MN; E. Claire Dees, University of North Carolina, Chapel Hill, NC; Rita Nanda, University of Chicago, Chicago, IL; Mothaffar F. Rimawi, Baylor College of Medicine, Houston, TX; and Antonio C. Wolff, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD. · Pubmed 26169615
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Pubmed 25847936
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • William M. Sikov, Miriam Hospital and Alpert Medical School of Brown University, Providence, RI; Donald A. Berry, University of Texas MD Anderson Cancer Center, Houston, TX; Charles M. Perou and Lisa A. Carey, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill; Constance T. Cirrincione, Alliance Statistical Center, Durham; Charles S. Kuzma, Southeast Cancer Control Consortium, Winston-Salem, NC; Baljit Singh, New York University Medical Center; Elisa R. Port, Mount Sinai Medical Center; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Sara M. Tolaney, Mehra Golshan, Jennifer R. Bellon, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Timothy J. Pluard, Washington University-St Louis Medical Center, St Louis, MO; George Somlo, City of Hope Comprehensive Cancer Center, Duarte; Deborah Collyar, Patient Advocates in Research, Danville, CA; and Olwen M. Hahn, University of Chicago Medical Center, Chicago, IL. · William M. Sikov, Miriam Hospital and Alpert Medical School of Brown University, Providence, RI; Donald A. Berry, University of Texas MD Anderson Cancer Center, Houston, TX; Charles M. Perou and Lisa A. Carey, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill; Constance T. Cirrincione, Alliance Statistical Center, Durham; Charles S. Kuzma, Southeast Cancer Control Consortium, Winston-Salem, NC; Baljit Singh, New York University Medical Center; Elisa R. Port, Mount Sinai Medical Center; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Sara M. Tolaney, Mehra Golshan, Jennifer R. Bellon, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Timothy J. Pluard, Washington University-St Louis Medical Center, St Louis, MO; George Somlo, City of Hope Comprehensive Cancer Center, Duarte; Deborah Collyar, Patient Advocates in Research, Danville, CA; and Olwen M. Hahn, University of Chicago Medical Center, Chicago, IL. · Pubmed 25092775
  • Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB). · Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB). · Pubmed 26113580
2014
  • Lineberger Comprehensive Cancer Center, University of North Carolina, 450 West Drive, Campus Box 7295, Chapel Hill, NC, 27599, USA, · Pubmed 25001612
  • Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Dana Farber Cancer Institute, Boston, MA; City of Hope National Medical Center, Duarte, CA; and Memorial Sloan Kettering Cancer Center, New York, NY · Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Dana Farber Cancer Institute, Boston, MA; City of Hope National Medical Center, Duarte, CA; and Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 25074878
  • Lawrence N. Shulman, Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Donald A. Berry, MD Anderson Cancer Center, Houston, TX; Constance T. Cirrincione, Gretchen Kimmick, Duke University Medical Center, Durham; Hyman Muss, University of North Carolina at Chapel Hill, Chapel Hill, NC; Heather P. Becker, University of Chicago, Chicago, IL; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Ruth O'Regan, Emory University, Atlanta, GA; Silvana Martino, The Angeles Clinic and Research Institute, Los Angeles, CA; Charles L. Shapiro, The James Cancer Center, Ohio State University, Columbus, OH; Charles J. Schneider, Christiana Healthcare Services, Wilmington, DE; Larry Norton, Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY. · Lawrence N. Shulman, Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Donald A. Berry, MD Anderson Cancer Center, Houston, TX; Constance T. Cirrincione, Gretchen Kimmick, Duke University Medical Center, Durham; Hyman Muss, University of North Carolina at Chapel Hill, Chapel Hill, NC; Heather P. Becker, University of Chicago, Chicago, IL; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Ruth O'Regan, Emory University, Atlanta, GA; Silvana Martino, The Angeles Clinic and Research Institute, Los Angeles, CA; Charles L. Shapiro, The James Cancer Center, Ohio State University, Columbus, OH; Charles J. Schneider, Christiana Healthcare Services, Wilmington, DE; Larry Norton, Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24934787
  • Vanessa B. Sheppard, Leigh Anne Faul, George Luta, Jonathan D. Clapp, Judy Huei-yu Wang, Claudine Isaacs, Michelle Tallarico, and Jeanne S. Mandelblatt, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Rachel L. Yung and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Gretchen Kimmick, William T. Barry, Brandelyn N. Pitcher, and Harvey J. Cohen, Duke University Medical Center; William T. Barry and Brandelyn N. Pitcher, Cancer and Leukemia Group B Statistical Center, Durham; Hyman B. Muss, University of North Carolina Chapel Hill, Chapel Hill, NC; Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Arti Hurria, City of Hope, Los Angeles, CA. · Vanessa B. Sheppard, Leigh Anne Faul, George Luta, Jonathan D. Clapp, Judy Huei-yu Wang, Claudine Isaacs, Michelle Tallarico, and Jeanne S. Mandelblatt, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Rachel L. Yung and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Gretchen Kimmick, William T. Barry, Brandelyn N. Pitcher, and Harvey J. Cohen, Duke University Medical Center; William T. Barry and Brandelyn N. Pitcher, Cancer and Leukemia Group B Statistical Center, Durham; Hyman B. Muss, University of North Carolina Chapel Hill, Chapel Hill, NC; Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Arti Hurria, City of Hope, Los Angeles, CA. · Pubmed 24934786
2012
  • Hematology/Oncology, University of North Carolina-Lineberger Comprehensive Cancer Center, 170 Manning Dr., Chapel Hill, NC 27599-7305, USA. · Pubmed 22665533
2010
  • University of North Carolina, 170 Manning Drive, Chapel Hill, NC 27599-7305, USA. · Pubmed 20877296
  • University of North Carolina, Chapel Hill, 27517, USA. · Pubmed 20858840
Probable:    Memorial Sloan-Kettering Cancer Center   Contact    
2015
  • Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Memorial Sloan Kettering Cancer Center, New York, New York, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Massachusetts General Hospital, Boston, Massachusetts, USA. · Dana-Farber Cancer Institute, Boston, Massachusetts, USA; Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Memorial Sloan Kettering Cancer Center, New York, New York, USA; Brigham and Women's Hospital, Boston, Massachusetts, USA; Massachusetts General Hospital, Boston, Massachusetts, USA · Pubmed 26240134
2017
  • Rachel A. Freedman, Eric P. Winer, and Ann H. Partridge, Dana-Farber Cancer Institute, Boston, MA; Jared C. Foster, Drew K. Seisler, Jacqueline M. Lafky, and Aminah Jatoi, Mayo Clinic; Jared C. Foster and Drew K. Seisler, Mayo Cancer Center, Rochester, MN; Hyman B. Muss and Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Harvey J. Cohen, Constance Cirrincione, and Gretchen Kimmick, Duke University, Durham, NC; Jeanne Mandelblatt, Georgetown University, Washington, DC; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; Alvaro Moreno-Aspitia, Mayo Clinic, Jacksonville, FL; and Arti Hurria, City of Hope, Duarte, CA. · Pubmed 27992272
2016
  • Harold J. Burstein and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester, Rochester, NY; Thomas A. Buchholz and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, BC; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Alexander J. Solky, Interlakes Oncology and Hematology PC, Rochester, NY; Vered Stearns, Johns Hopkins, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Harold J. Burstein and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Christina Lacchetti, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester, Rochester, NY; Thomas A. Buchholz and Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, BC; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Alexander J. Solky, Interlakes Oncology and Hematology PC, Rochester, NY; Vered Stearns, Johns Hopkins, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Pubmed 26884586
  • From the Massachusetts General Hospital Cancer Center, Avon International Breast Cancer Research Program (P.E.G.), Harvard Medical School (P.E.G., E.W.), and Dana-Farber Cancer Institute (E.W.), Boston; the Department of Oncology, Mayo Clinic, Rochester, MN (J.N.I., J.S.K.); Sunnybrook Odette Cancer Centre, Toronto (K.I.P.), British Columbia Cancer Agency, Vancouver (K.G.), Canadian Cancer Trials Group, Queen's University, Kingston, ON (K.W., D.T., W.R.P.), Department of Oncology, McMaster University, Hamilton, ON (T.W.), and Dalhousie University Faculty of Medicine, Moncton Hospital, Moncton, NB (S.R.) - all in Canada; Virginia Cancer Specialists-US Oncology Network, Fairfax (N.J.R.); University of North Carolina-Lineberger Comprehensive Cancer Center, Chapel Hill (H.M.); University of Washington School of Medicine, Seattle (J.G.); Center of Oncology and Hematology, Wilheminen Hospital, Vienna (K.S.-W.); Colorado Cancer Research Program, Denver (K.S.); Johns Hopkins Kimmel Cancer Center, Baltimore (A.C.W.); Memorial Sloan Kettering Cancer Center, New York (C.H.); University of Arizona, Tucson (A.S.); and Highlands Oncology Group, Fayetteville, AR (J.T.B.). · Pubmed 27264120
  • Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Maura N. Dickler, Mary Ellen Moynahan, Diana E. Lake, and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; William T. Barry, Dana-Farber Cancer Institute; Eric P. Winer, Dana-Farber/Partners Cancer Care, Boston, MA; Constance T. Cirrincione, Duke University, Durham, NC; Matthew J. Ellis, Baylor College of Medicine; Debasish Tripathy, The University of Texas MD Anderson Cancer Center, Houston, TX; Federico Innocenti and Lisa A. Carey, University of North Carolina at Chapel Hill, Chapel Hill, NC; Arti Hurria, City of Hope, Duarte; Hope S. Rugo, University of California at San Francisco, San Francisco, CA; Olwen Hahn, Alliance for Clinical Trials in Oncology, Chicago, IL; and Bryan P. Schneider, Indiana University School of Medicine, Indianapolis, IN. · Pubmed 27138575
  • Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Lisa A. Carey, David W. Ollila, Carey K. Anders, Katherine A. Hoadley, Michael Iglesia, and Charles M. Perou, University of North Carolina Chapel Hill, Chapel Hill; Constance T. Cirrincione and Brandelyn N. Pitcher, Alliance Statistics and Data Center, Duke University, Durham, NC; Donald A. Berry, Alliance Statistics and Data Center, MD Anderson, Houston, TX; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Ian E. Krop and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Lyndsay N. Harris, University Hospitals of Cleveland, Cleveland, OH; Norah Lynn Henry, University of Michigan, Ann Arbor, MI; Douglas J. Weckstein, New Hampshire Hematology-Oncology, Hooksett, NH; Baljit Singh, New York University; Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Maggie Chon U. Cheang, Clinical Trials and Statistics Unit, Institute of Cancer Research, Belmont, United Kingdom. · Pubmed 26527775
2015
  • *Department of Surgery, Brigham and Women's Hospital, Boston, MA †Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC ‡Department of Medical Oncology Women and Infants Hospital and Alpert Medical School of Brown University, Providence, RI §Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX ¶Department of Medical Oncology, Maine Center for Cancer Medicine, Scarborough, ME ∥Department of Medical Oncology, City of Hope Medical Center, Los Angeles, CA **Department of Medical Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY ††Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and ‡‡Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, NC. · Pubmed 26222764
  • Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Hope S. Rugo, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; William T. Barry, Alliance Statistics and Data Center, Dana-Farber Cancer Institute; Erica L. Mayer and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Alvaro Moreno-Aspitia and Edith A. Perez, Mayo Clinic, Jacksonville, FL; Alan P. Lyss, Heartland Cancer Research Community Clinical Oncology Program; Michael Naughton, Washington University School of Medicine, St Louis, MO; Constance Cirrincione and Eleanor Leung, Alliance Statistics and Data Center, Duke University, Durham; Lisa A. Carey, University of North Carolina, Chapel Hill, NC; Deborah Toppmeyer, Cancer Institute of New Jersey, New Brunswick, NJ; and Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26056183
  • Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT. · Pubmed 25847936
  • From the Departments of Medical Oncology (S.M.T., B.A.O., A.H.P., I.E.K., H.J.B., E.P.W.) and Biostatistics and Computation Biology (W.T.B., H.G.), Dana-Farber Cancer Institute, and Department of Hematology-Oncology, Massachusetts General Hospital (B.M.) - both in Boston; Breast Cancer Medicine Service, Department of Medicine, Solid Tumor Division, Memorial Sloan Kettering Cancer Center, and Department of Medicine, Weill Cornell Medical Center, New York (C.T.D., C.A.H.), and Department of Medical Oncology, Hofstra North Shore-LIJ School of Medicine, New Hyde Park (I.S.) - all in New York; Sarah Cannon Cancer Center, Department of Medical Oncology, Nashville (D.A.Y.); Department of Medicine, Division of Medical Oncology, Duke Cancer Institute, Durham (P.K.M.), and Department of Medical Oncology, University of North Carolina, Chapel Hill (L.A.C.) - both in North Carolina; Cardinal Bernardin Cancer Center, Department of Medicine, Division of Hematology-Oncology, Loyola University Chicago Stritch School of Medicine, Maywood, IL (K.S.A.); Comprehensive Cancer Center, Department of Medicine, Division of Oncology, University of California, San Francisco, San Francisco (H.S.R.); Department of Medical Oncology, Washington University in St. Louis, St. Louis (M.E.); and Johns Hopkins Kimmel Cancer Center, Department of Oncology, Baltimore (A.C.W.). · Pubmed 25564897
  • William M. Sikov, Miriam Hospital and Alpert Medical School of Brown University, Providence, RI; Donald A. Berry, University of Texas MD Anderson Cancer Center, Houston, TX; Charles M. Perou and Lisa A. Carey, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill; Constance T. Cirrincione, Alliance Statistical Center, Durham; Charles S. Kuzma, Southeast Cancer Control Consortium, Winston-Salem, NC; Baljit Singh, New York University Medical Center; Elisa R. Port, Mount Sinai Medical Center; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Sara M. Tolaney, Mehra Golshan, Jennifer R. Bellon, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Timothy J. Pluard, Washington University-St Louis Medical Center, St Louis, MO; George Somlo, City of Hope Comprehensive Cancer Center, Duarte; Deborah Collyar, Patient Advocates in Research, Danville, CA; and Olwen M. Hahn, University of Chicago Medical Center, Chicago, IL. · William M. Sikov, Miriam Hospital and Alpert Medical School of Brown University, Providence, RI; Donald A. Berry, University of Texas MD Anderson Cancer Center, Houston, TX; Charles M. Perou and Lisa A. Carey, University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill; Constance T. Cirrincione, Alliance Statistical Center, Durham; Charles S. Kuzma, Southeast Cancer Control Consortium, Winston-Salem, NC; Baljit Singh, New York University Medical Center; Elisa R. Port, Mount Sinai Medical Center; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Sara M. Tolaney, Mehra Golshan, Jennifer R. Bellon, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Timothy J. Pluard, Washington University-St Louis Medical Center, St Louis, MO; George Somlo, City of Hope Comprehensive Cancer Center, Duarte; Deborah Collyar, Patient Advocates in Research, Danville, CA; and Olwen M. Hahn, University of Chicago Medical Center, Chicago, IL. · Pubmed 25092775
  • Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB). · Dana-Farber Cancer Institute, Boston, MA (JAL, EW); Alliance Statistics and Data Center, Durham, NC (CTC); Mayo Clinic, Rochester, MN (ML, JNI); Hofstra North Shore - LIJ School of Medicine, ProHEALTH Care Associates, Lake Success, NY (MC); Northwestern University Feinberg School of Medicine, Chicago, IL (WG); The Angeles Clinic and Research Institute, Santa Monica, CA (SM); Rhode Island Hospital, Providence, RI (WS); St. Barnabas Medical Center, Livingston, NJ (RM); The Genome Institute, Washington University in St. Louis, St. Louis, MO (EM); Department of Genetics, Lineberger Cancer Center, University of North Carolina, Chapel Hill, NC (CMP); Breast Cancer Program, Siteman Cancer Center and Washington University School of Medicine, St. Louis, MO (ME); Memorial Sloan Kettering Cancer Center, New York, NY (CAH); Alliance Statistics and Data Center, MD Anderson Cancer Center, Houston, TX (DB); Alliance Statistics and Data Center, Dana-Farber Cancer Institute, Boston, MA (WTB). · Pubmed 26113580
2014
  • Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester; Alexander J. Solky, Interlakes Onc and Hem PC, Rochester; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas A. Buchholz, Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston; Diana Rowden, Dallas, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Vered Stearns, Johns Hopkins School of Medicine, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Holly Anderson, Breast Cancer Coalition of Rochester; Alexander J. Solky, Interlakes Onc and Hem PC, Rochester; Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; Thomas A. Buchholz, Sharon H. Giordano, The University of Texas MD Anderson Cancer Center, Houston; Diana Rowden, Dallas, TX; Nancy E. Davidson, University of Pittsburgh Cancer Institute and UPMC Cancer Center, Pittsburgh, PA; Karen E. Gelmon, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Vered Stearns, Johns Hopkins School of Medicine, Baltimore, MD; and Jennifer J. Griggs, University of Michigan, Ann Arbor, MI. · Pubmed 24868023
  • Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando; Edith A. Perez, Mayo Clinic, Jacksonville; Jennifer Levinson, Ponte Vedra Beach, FL; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Ian Krop, Eric P. Winter, and Nancy U. Lin, Dana-Farber Cancer Institute, Boston, MA; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799487
  • Sharon H. Giordano and Ana M. Gonzalez-Angulo, University of Texas MD Anderson Cancer Center, Houston; Debra A. Patt, Texas Oncology, Austin, TX; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Jeffrey J. Kirshner, Hematology/Oncology Associates of Central New York, East Syracuse; Sarat Chandarlapaty and Shanu Modi, Memorial Sloan Kettering Cancer Center; Francisco J. Esteva, New York University Cancer Institute, New York, NY; Jennie R. Crews, PeaceHealth St Joseph Cancer Center, Bellingham, WA; Nancy E. Davidson, University of Pittsburgh Cancer Institute and University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA; Ian Krop, Nancy U. Lin, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Jennifer Levinson, Ponte Vedra Beach; Edith A. Perez, Mayo Clinic, Jacksonville; Naren Ramakrishna, University of Florida Health Cancer Center at Orlando Health, Orlando, FL; and Jane Perlmutter, Ann Arbor, MI. · Pubmed 24799465
  • Harold J. Burstein, William T. Barry, Sara M. Tolaney, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Constance T. Cirrincione, Duke University Alliance Statistics and Data Center; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; Helen K. Chew, University of California, Davis, Davis, CA; Diana E. Lake and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Cynthia Ma, Washington University School of Medicine, St Louis, MO. · Harold J. Burstein, William T. Barry, Sara M. Tolaney, and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Constance T. Cirrincione, Duke University Alliance Statistics and Data Center; Kimberly L. Blackwell, Duke University Medical Center, Durham, NC; Helen K. Chew, University of California, Davis, Davis, CA; Diana E. Lake and Clifford A. Hudis, Memorial Sloan Kettering Cancer Center, New York, NY; and Cynthia Ma, Washington University School of Medicine, St Louis, MO. · Pubmed 25348000
  • Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Dana Farber Cancer Institute, Boston, MA; City of Hope National Medical Center, Duarte, CA; and Memorial Sloan Kettering Cancer Center, New York, NY · Wake Forest School of Medicine, Winston-Salem; Alliance Statistics and Data Center, Duke University; Duke University Medical Center, Durham; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN; Dana Farber Cancer Institute, Boston, MA; City of Hope National Medical Center, Duarte, CA; and Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 25074878
  • Lawrence N. Shulman, Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Donald A. Berry, MD Anderson Cancer Center, Houston, TX; Constance T. Cirrincione, Gretchen Kimmick, Duke University Medical Center, Durham; Hyman Muss, University of North Carolina at Chapel Hill, Chapel Hill, NC; Heather P. Becker, University of Chicago, Chicago, IL; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Ruth O'Regan, Emory University, Atlanta, GA; Silvana Martino, The Angeles Clinic and Research Institute, Los Angeles, CA; Charles L. Shapiro, The James Cancer Center, Ohio State University, Columbus, OH; Charles J. Schneider, Christiana Healthcare Services, Wilmington, DE; Larry Norton, Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY. · Lawrence N. Shulman, Harold J. Burstein, Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Donald A. Berry, MD Anderson Cancer Center, Houston, TX; Constance T. Cirrincione, Gretchen Kimmick, Duke University Medical Center, Durham; Hyman Muss, University of North Carolina at Chapel Hill, Chapel Hill, NC; Heather P. Becker, University of Chicago, Chicago, IL; Edith A. Perez, Mayo Clinic, Jacksonville, FL; Ruth O'Regan, Emory University, Atlanta, GA; Silvana Martino, The Angeles Clinic and Research Institute, Los Angeles, CA; Charles L. Shapiro, The James Cancer Center, Ohio State University, Columbus, OH; Charles J. Schneider, Christiana Healthcare Services, Wilmington, DE; Larry Norton, Clifford A. Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY. · Pubmed 24934787
  • Vanessa B. Sheppard, Leigh Anne Faul, George Luta, Jonathan D. Clapp, Judy Huei-yu Wang, Claudine Isaacs, Michelle Tallarico, and Jeanne S. Mandelblatt, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Rachel L. Yung and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Gretchen Kimmick, William T. Barry, Brandelyn N. Pitcher, and Harvey J. Cohen, Duke University Medical Center; William T. Barry and Brandelyn N. Pitcher, Cancer and Leukemia Group B Statistical Center, Durham; Hyman B. Muss, University of North Carolina Chapel Hill, Chapel Hill, NC; Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Arti Hurria, City of Hope, Los Angeles, CA. · Vanessa B. Sheppard, Leigh Anne Faul, George Luta, Jonathan D. Clapp, Judy Huei-yu Wang, Claudine Isaacs, Michelle Tallarico, and Jeanne S. Mandelblatt, Georgetown University Medical Center and Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC; Rachel L. Yung and Eric P. Winer, Dana-Farber Cancer Institute, Boston, MA; Gretchen Kimmick, William T. Barry, Brandelyn N. Pitcher, and Harvey J. Cohen, Duke University Medical Center; William T. Barry and Brandelyn N. Pitcher, Cancer and Leukemia Group B Statistical Center, Durham; Hyman B. Muss, University of North Carolina Chapel Hill, Chapel Hill, NC; Clifford Hudis, Memorial Sloan-Kettering Cancer Center, New York, NY; and Arti Hurria, City of Hope, Los Angeles, CA. · Pubmed 24934786
2013
  • Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, New York. · Pubmed 24037735
2012
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York 11725, USA. · Pubmed 21693770
2011
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 21372222
2010
  • Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA. · Pubmed 20479410
2009
  • Division of Solid Tumor Oncology, Department of Medicine, Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021-6007, USA. · Pubmed 19433391
  • Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Pubmed 19901120
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 213 total) written by Dr. Eric Winer about Breast Neoplasms:

  • Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. 2018
  • 3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3). 2017
  • 3rd ESO-ESMO international consensus guidelines for Advanced Breast Cancer (ABC 3). 2017
  • Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A Review. 2017
  • Neratinib Efficacy and Circulating Tumor DNA Detection of 2017
  • Kinetic-Pharmacodynamic Model of Chemotherapy-Induced Peripheral Neuropathy in Patients with Metastatic Breast Cancer Treated with Paclitaxel, Nab-Paclitaxel, or Ixabepilone: CALGB 40502 (Alliance). 2017
  • Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance). 2017
  • (no title) 2017
  • Phase I dose escalation study of the PI3kinase pathway inhibitor BKM120 and the oral poly (ADP ribose) polymerase (PARP) inhibitor olaparib for the treatment of high-grade serous ovarian and breast cancer. 2017
  • Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients. 2017
Show List of Full Article Records
Google Searches

Learn more about Dr. Eric Winer using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
University of North Carolina Chapel Hill
Memorial Sloan-Kettering Cancer Center
Affiliation Timeline What is this?
Harvard University
2017
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston. · Advanced Breast Cancer.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland. · Europa Donna, Nicosia, Cyprus. · European School of Oncology, Milan, Italy and Bellinzona, Switzerland. · Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France. · Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium. · Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France. · Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco. · Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore. · Indiana University Medical CTR, Indianapolis. · Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA. · Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany. · Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK. · Sandton Oncology Centre, Johannesburg, South Africa. · Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. · Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Pubmed 28177437
  • European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. Electronic address: · European School of Oncology, Milan, Italy; European School of Oncology, Bellinzona, Switzerland. · Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland. · Breast Center, Genolier Cancer Center, Genolier, Switzerland. · Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France. · Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil. · Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden. · Department of Medical Oncology, Fortis Hospital, Kolkata, India. · Medical Oncology Department, Hospital of Prato, Prato, Italy. · Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal. · Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center, USA. · METAvivor Research and Support, Annapolis, USA. · Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy. · Department of Medical Oncology, Institut Curie, Paris, France. · NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon. · Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania. · Brighton & Sussex Medical School, University of Sussex, Falmer, UK. · Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta. · Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia. · BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada. · Department of Medical Oncology, Galliera Hospital, Genoa, Italy. · Brustzentrum der Universitat München, Munich, Germany. · Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA. · Sheba Medical Center, Tel Hashomer, Israel. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA. · Advanced BC.org, New York, USA. · Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands. · Metastatic Breast Cancer Network US, Inversness, USA. · Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan. · Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland